Cardiff University has an excellent track record of commercially exploiting the outcomes of its research. Forming a company to exploit University know-how or expertise is one of the routes available, and is managed through a close working relationship with Fusion IP. Licensing and royalty agreements, which enable businesses to use Cardiff research commercially, bring enormous benefits to a range of companies. Examples of recent highlights and successes are shown below along with current opportunities. If you are interested in obtaining further information please contact us.
The ESRC’s Impact Acceleration Account panel met in January, awarding five projects Initiator funding to generate impact from research in a variety of areas: self-injury support, street harassment in Cairo, communication in dementia care, broadcasting impartiality during the general election and post-infertility treatment support.
New Cardiff University Trademark
A new trademark ‘WAVE’ was published by the Intellectual Property Office on behalf of Cardiff University on the 12th February 2015. WAVE – Women Adding Value to the Economy – is a collaboration between the School of Social Sciences at Cardiff, the University of South Wales and BAWSO. This project aims to target the causes in pay gaps between man and women in Wales.
IP workshops/courses for staff and students
The technology transfer team regularly delivers training for staff and students. Check out the University training and development programme for the Patent Searching on the Internet workshop and the Intellectual Property and Copyright course!
IPCoP features in National Centre for Universities and Business Annual Report
This year, the annual NCUB State Of The Relationship report focuses on Collaborations. HEFCW have selected the IPCoP to feature as its case study of successful place-based collaboration. NCUB is an independent and not-for-profit organisation, whose members include leading FTSE350 businesses and universities of all mission groups. It aims to promote, develop and support university-business collaboration across the UK.
Double MRC Success
Cardiff University successful in securing £300K from the MRC Confidence-in-Concept scheme to support <£50K projects with commercial/clinical potential (call due March 2015). An additional £125K was awarded via the MRC Proximity-to-Discovery Scheme, to support academic-industry interaction.
“Stop the Spread” faces down tough competition at iSolve
An educational board game aimed at teaching children about cancer and its treatment has won the 2015 Cardiff iSolve competition. The “Stop the Spread” team delivered their findings to the inventors of the game and other invited guests at an event held in the Council Chamber on the 18th February. The game is currently being developed by Karen Reed and Giusy Tournillo of ECSCRI with assistance from the Technology Transfer Team. The inventors have been delighted with the valuable input provided by their iSolve team members and will be unveiling a fully featured prototype game at an educational trade fair later this year.
New research tool for cancer biologists
Licence terms have been agreed with one of the world’s largest suppliers of research reagents for a novel ZIP7 monoclonal antibody developed by Dr. Kathryn Taylor of the Cardiff School of Pharmacy and Pharmaceutical Sciences. The importance of ZIP7 in cancer biology has been elucidated over recent years by Dr. Taylor in a number of high profile publications. The availability of this tool will be valuable to cancer biologists and other scientists studying the role of zinc in cellular signalling.
Partnership with Tiziana Pharmaceuticals to support work on a novel anti-cancer agent
Share issue conditionally raises £20m for Fusion IP, who have agreed deals to work with Swansea University and the University of Nottingham
MedaPhor group plc, a company spun out of research at Cardiff University, has today floated on the AIM market of the London Stock Exchange
Positive progress for Diurnal's CATCH (Chronocort® As Treatment for Congenital Adrenal Hyperplasia) clinical study
Fault Current Limited (“FCL”), has been awarded a £635,000 grant from the Department of Energy and Climate Change (DECC)
Exclusive distribution agreement with Tellyes Scientific Inc (“Tellyes”) to sell MedaPhor’s range of ultrasound simulators into mainland China
'First-In-Man' Trials Success for Ultravision™ Technology